Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

ARV-771

SKU: orb1301792

Description

ARV-771 is a potent PROTAC-based degrader of BET proteins, exhibiting high affinity for BRD2, BRD3, and BRD4 bromodomains with Kd values in the single-digit nanomolar range. This compound is a valuable chemical probe for investigating BET protein function in cancer research, demonstrating efficacy in both cellular assays and in vivo tumor models.

Research Area

Epigenetics & Chromatin, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number1949837-12-0
MW986.64
Purity99.69% (May vary between batches)
FormulaC49H60ClN9O7S2
SMILESO=C([C@H]1N(C([C@H](C(C)(C)C)/N=C(O)/COCCCOCCNC(C[C@H]2C3=NN=C(C)N3C4=C(C(C)=C(C)S4)C(C5=CC=C(Cl)C=C5)=N2)=O)=O)C[C@H](O)C1)N[C@H](C6=CC=C(C7=C(C)N=CS7)C=C6)C
TargetPROTACs,Epigenetic Reader Domain
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (2.03 mM);DMSO:10 mM

Bioactivity

Target IC50
BRD2(1):34 nM (Kd)|BRD3(1):8.3 nM (Kd)|BRD4(1):9.6 nM (Kd)|BRD4(2):7.6 nM (Kd)|BRD3(2):7.6 nM (Kd)|BRD2(2):4.7 nM (Kd)
In Vivo
METHODS: Nude mice successfully bearing transplanted HepG2 cell tumors were randomly divided into two groups and treated with ARV-771 (20 mg/kg/day, subcutaneous injection) every other day for 25 days. Tumor volume and body weight of mice were measured every 5 days. Immediately after extraction of xenografts from mice, tumor weight was measured by an electronic balance. RESULTS After ARV-771 treatment, tumor volume and tumor weight were significantly reduced. Immunochemical detection results showed that ARV-771 reduced the expression of Ki67 and increased the expression of cleaved Caspase 3 in xenograft tissues.
In Vitro
METHODS: ARV-771 (0.01/0.025/0.05/0.1/0.25/0.5/1/2μM) was used to culture Hep3B, HepG and HCCLM3 cells to observe whether ARV-771 inhibits the growth of these cancer cells. RESULTS ARV-771 had a dose-dependent inhibition on cancer cell viability when the concentration reached 0.25 μM in Hep3B and HepG2 cells and 0.5 μM in HCCLM3 cells.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

inhibit, EpigeneticReaderDomain, Epigenetic Reader Domain, Inhibitor, ARV 771, ARV771, ARV-771, BET, PROTACs

Similar Products

  • VHL ligand 2 hydrochloride [orb611997]

    >98%

    1948273-03-7

    413.4

    C21H18F3N5O

    1 g, 2 g, 5 g
  • (S,R,S)-AHPC-Me [orb1299538]

    99.86% (May vary between batches)

    1948273-02-6

    444.59

    C23H32N4O3S

    25 mg, 50 mg, 100 mg
  • (S,R,S)-AHPC-Me hydrochloride [orb1308828]

    99.27% (May vary between batches)

    1948273-03-7

    481.051

    C23H33ClN4O3S

    50 mg
  • (S,R,S)-AHPC-Me dihydrochloride [orb1707973]

    517.51

    C23H34Cl2N4O3S

    100 mg, 5 mg, 10 mg, 25 mg, 50 mg
  • PROTAC BRD4 Degrader-39 [orb3175220]

    50 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 100.00
5 mg
$ 170.00
10 mg
$ 240.00
1 ml x 10 mM (in DMSO)
$ 260.00
25 mg
$ 440.00
50 mg
$ 620.00
100 mg
$ 860.00
200 mg
$ 1,120.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry